Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension

NCT00437645 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1183

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Valsartan 160 mg capsules
DRUG: Amlodipine 5 mg capsules
DRUG: placebo

Sponsor

Novartis Pharmaceuticals